• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价缺血性结肠炎的治疗方法。

Systematic review on the treatment of ischaemic colitis.

机构信息

Department of Colorectal Surgery, Royal Free Hospital, NHS Trust & University College London, London, UK.

出版信息

Colorectal Dis. 2011 Jul;13(7):744-7. doi: 10.1111/j.1463-1318.2010.02272.x. Epub 2010 Mar 30.

DOI:10.1111/j.1463-1318.2010.02272.x
PMID:20374265
Abstract

AIM

Ischaemic colitis is uncommon. Aetiological factors include abdominal aortic surgery, drugs (especially inotropics) or rheumatoid diseases, such as Takayasu's or Buerger's diseases. However, there is often no triggering factor, and it may be part of multifactorial cardiac, respiratory, renal or metabolic failure.

METHOD

A systematic review of the current literature on the management of ischaemic colitis was carried out.

RESULTS

Ten retrospective trials (841 patients) were included. No randomized controlled or prospective trial of the management of ischaemic colitis was found.

CONCLUSION

There is very little evidence base for the management of this condition.

摘要

目的

缺血性结肠炎并不常见。病因包括腹主动脉手术、药物(特别是正性肌力药)或类风湿性疾病,如 Takayasu 病或伯格氏病。然而,通常没有触发因素,它可能是多因素心脏、呼吸、肾脏或代谢衰竭的一部分。

方法

对缺血性结肠炎的当前文献进行了系统回顾。

结果

纳入了 10 项回顾性试验(841 例患者)。未发现缺血性结肠炎管理的随机对照或前瞻性试验。

结论

对于这种疾病的治疗,证据基础非常有限。

相似文献

1
Systematic review on the treatment of ischaemic colitis.系统评价缺血性结肠炎的治疗方法。
Colorectal Dis. 2011 Jul;13(7):744-7. doi: 10.1111/j.1463-1318.2010.02272.x. Epub 2010 Mar 30.
2
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
3
Antiseptics for burns.烧伤用防腐剂
Cochrane Database Syst Rev. 2017 Jul 12;7(7):CD011821. doi: 10.1002/14651858.CD011821.pub2.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Topical antiseptics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗菌剂。
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013055. doi: 10.1002/14651858.CD013055.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Antibiotics for the induction and maintenance of remission in ulcerative colitis.溃疡性结肠炎诱导缓解和维持缓解的抗生素治疗。
Cochrane Database Syst Rev. 2022 May 18;5(5):CD013743. doi: 10.1002/14651858.CD013743.pub2.
9
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.用于囊性纤维化患者肺部加重期的静脉用抗生素
Cochrane Database Syst Rev. 2025 Jan 20;1(1):CD009730. doi: 10.1002/14651858.CD009730.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Precision medicine in intestinal ischemia: the emerging role of biomarkers.肠道缺血中的精准医学:生物标志物的新兴作用
Intern Emerg Med. 2025 Mar;20(2):369-379. doi: 10.1007/s11739-024-03808-z. Epub 2024 Nov 8.
2
Ischemic Colitis Is a Risk Factor for Clostridium difficile Infection.缺血性结肠炎是艰难梭菌感染的一个危险因素。
Cureus. 2022 Jun 19;14(6):e26076. doi: 10.7759/cureus.26076. eCollection 2022 Jun.
3
Outcomes of patients with ischemic colitis causing severe hematochezia managed medically or surgically.缺血性结肠炎导致严重血便患者的医学或手术治疗结果。
Langenbecks Arch Surg. 2022 Jun;407(4):1625-1636. doi: 10.1007/s00423-022-02441-8. Epub 2022 Feb 21.
4
The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis.抗菌治疗对缺血性结肠炎患者的不确定疗效
J Clin Med. 2020 Jul 10;9(7):2182. doi: 10.3390/jcm9072182.
5
Predictors of mortality following emergency open colectomy for ischemic colitis: a single-center experience.缺血性结肠炎行急诊剖腹结肠切除术患者的死亡预测因素:单中心经验
World J Emerg Surg. 2020 Jun 29;15(1):40. doi: 10.1186/s13017-020-00321-4.
6
The Pathophysiology, Presentation and Management of Ischaemic Colitis: A Systematic Review.缺血性结肠炎的病理生理学、临床表现和治疗:系统评价。
World J Surg. 2020 Mar;44(3):927-938. doi: 10.1007/s00268-019-05248-9.
7
Ischemic colitis caused increased early and delayed mortality.缺血性结肠炎导致早期和晚期死亡率增加。
World J Emerg Surg. 2018 Jul 11;13:31. doi: 10.1186/s13017-018-0193-2. eCollection 2018.
8
Advents in the Diagnosis and Management of Ischemic Colitis.缺血性结肠炎的诊断与管理进展
Front Surg. 2017 Sep 4;4:47. doi: 10.3389/fsurg.2017.00047. eCollection 2017.
9
Update on Colon Ischemia: Recent Insights and Advances.结肠缺血的最新进展:近期见解与进展
Curr Gastroenterol Rep. 2015 Dec;17(12):45. doi: 10.1007/s11894-015-0469-6.
10
Pseudomembranous colitis.伪膜性结肠炎
Dis Mon. 2015 May;61(5):181-206. doi: 10.1016/j.disamonth.2015.01.006. Epub 2015 Mar 11.